Synapse - Rui Wang

Results (24)

Impact of baseline expectancy on outcome prediction of real and sham acupuncture for persistent chemotherapy-induced peripheral neuropathy pain in solid tumor survivors: A secondary analysis of a randomized clinical trial

Journal Article

Li, X.; Zhi, L.; Han, K. Y.; Li, S. Q.; Ahmad, K.; Seluzicki, C.; Wang, R.; Bao, T.
Integrative Cancer Therapies (2023)

Fulltext@MSK | Save

How often do sentinel lymph node biopsy results affect adjuvant therapy decisions among postmenopausal women with early-stage HR+/HER2− breast cancer in the post-RxPONDER era?

Journal Article

Pilewskie, M.; Sevilimedu, V.; Eroglu, I.; Le, T.; Wang, R.; Morrow, M.; Braunstein, L. Z.
Annals of Surgical Oncology (2022)

Fulltext@MSK | Save

ASO Visual Abstract: How often do sentinel lymph node biopsy results affect adjuvant therapy decisions among postmenopausal women with early-stage HR+/HER2- breast cancer in the post-RxPONDER era?

Miscellaneous

Pilewskie, M.; Sevilimedu, V.; Eroglu, I.; Le, T.; Wang, R.; Morrow, M.; Braunstein, L. Z.
Annals of Surgical Oncology (2022)

Fulltext@MSK | Save

How often do sentinel lymph node biopsy results impact adjuvant therapy decisions among postmenopausal women with early stage, HR+/HER2= breast cancer in the post-RxPonder era?

Meeting Abstract

Pilewskie, M.; Sevilimedu, V.; Eroglu, I.; Le, T.; Wang, R.; Morrow, M.; Braunstein, L.
Annals of Surgical Oncology (2022)

Fulltext@MSK | Save

Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC)

Meeting Abstract

Wang, R.; Singh, J. C.; Wong, S. T. L.; Lake, D.; Iyengar, N. M.; D'Andrea, G.; Brockway-Marchello, J. P.; Kaba, A.; Traina, T. A.; Robson, M. E.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

A phase I study of alpelisib in combination with trastuzumab and LJM716 in patients with PIK3CA-mutated HER2-positive metastatic breast cancer

Journal Article

Jhaveri, K.; Drago, J. Z.; Shah, P. D.; Wang, R.; Pareja, F.; Ratzon, F.; Iasonos, A.; Patil, S.; Rosen, N.; Fornier, M. N.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Measuring tumor epichaperome expression using [(124)I] PU-H71 positron emission tomography as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2-negative metastatic breast cancer

Journal Article

Jhaveri, K. L.; dos Anjos, C. H.; Taldone, T.; Wang, R.; Comen, E.; Fornier, M.; Bromberg, J. F.; Ma, W.; Patil, S.; Rodina, A.; more...
JCO Precision Oncology (2020)

Fulltext@MSK | Save

Neoadjuvant treatment in breast cancer

Book Section

Wang, R.; Dang, C.
In Urban, C.; Rietjens, M.; El-Tamer, M.; Sacchini, V. S. (Eds.) Oncoplastic and Reconstructive Breast Surgery. 2nd ed (2019)

Fulltext@MSK | Save

Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes

Journal Article

Lowery, M. A.; Goff, L. W.; Keenan, B. P.; Jordan, E.; Wang, R.; Bocobo, A. G.; Chou, J. F.; O’Reilly, E. M.; Harding, J. J.; Kemeny, N.; more...
Cancer (2019)

Fulltext@MSK | Save

Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC)

Meeting Abstract

Wang, R.; Singh, J.; Sterlin, V.; Goldstein, M.; Lake, D.; Wong, S.; Baselga, J.; Norton, L.; Dang, C.
Cancer Research (2019)

Fulltext@MSK | Save